Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR
about
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirusPhospholipid scramblase 1 mediates hepatitis C virus entry into host cellsInhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue virusesHepatitis C virus proteinsDominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infectionScavenger receptor BI and BII expression levels modulate hepatitis C virus infectivityDC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by plateletsInitiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type ITransmission of human hepatitis C virus from patients in secondary cells for long term cultureImmunological functions of liver sinusoidal endothelial cellsDendritic cells: The warriors upfront-turned defunct in chronic hepatitis C infectionAutophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseasesDendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing AntibodiesRole of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins.Tetraspanins in viral infections: a fundamental role in viral biology?N-Linked Glycosylation of West Nile Virus Envelope Proteins Influences Particle Assembly and InfectivityAnalysis of a Highly Flexible Conformational Immunogenic Domain A in Hepatitis C Virus E2Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and InfectionCharacterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter VirusesEvaluating Replication-Defective Vesicular Stomatitis Virus as a Vaccine VehicleL-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virusIdentification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 BindingDiverse CD81 Proteins Support Hepatitis C Virus InfectionHepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particlesExpression of DC-SIGN and DC-SIGNR on Human Sinusoidal EndotheliumVirological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemiaPoly(I:C) and Lipopolysaccharide Innate Sensing Functions of Circulating Human Myeloid Dendritic Cells Are Affected In Vivo in Hepatitis C Virus-Infected PatientsHepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and NeutralizationHepatitis C Virus Inhibits Cell Surface Expression of HLA-DR, Prevents Dendritic Cell Maturation, and Induces Interleukin-10 ProductionDissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 bindingCD81-Dependent Binding of Hepatitis C Virus E1E2 HeterodimersCD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human HepatocytesDC-SIGN and L-SIGN Can Act as Attachment Receptors for Alphaviruses and Distinguish between Mosquito Cell- and Mammalian Cell-Derived VirusesIdentification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing AntibodiesAnalysis of a conserved RGE/RGD motif in HCV E2 in mediating entryMutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entry
P2860
Q24307914-8ADF0761-F441-4C55-8680-C1A479DFFF26Q24318390-AD74F1FA-E939-4813-AA6B-352A6816F3A2Q24519072-704F6862-B48D-4FDD-9F02-D4E68A8133F9Q24536024-E4FD0641-964A-4B1D-A6B7-96D48420DF92Q24563969-F36BBF86-2835-46AF-9059-F3DB958E2324Q24658465-F43CA534-9344-4F5B-8134-FBC0998D09FAQ24672232-B64FB5D1-151D-4583-B8EB-911F81EB87F8Q24673797-F84E5640-A16D-4657-8D16-001F146DFEA2Q24676039-C2B008BF-7BB3-4C4F-8D5D-3DA3A4674752Q24800686-1FAA2174-75EC-4584-8922-48D96C3AC6EDQ26753027-AB7B103C-F645-48BC-9450-A43A90D35458Q26784265-919F8EF8-9F05-4476-A683-F232C4F1D979Q26992256-4AC85E09-6EDA-4A21-8EDE-FD8A82B5D197Q27010312-172140F0-A3A0-4576-9347-ABF70D54209AQ27469468-CABB8874-BA2C-4D55-B8F0-C7D259436702Q27469837-DB0BF00C-A317-4F2F-8083-5F9103E363FEQ27469844-F424088C-9F86-4555-8424-81A362B6859DQ27470936-38C7A08C-6523-4952-B8FC-71056C7D82FEQ27472669-75186430-1529-49FF-AD29-E7D50E2A294FQ27472672-E876082A-9642-44DC-B3D4-A64FBF4ADC0AQ27472768-D2D7F438-9BED-4503-9E0C-819B21B1FEB2Q27472821-4487653A-3A06-4B34-8079-13E239066AF4Q27473226-ECC54BFE-55C8-4EC4-BEE0-0FD1A0E8B099Q27473287-E5CA1BC6-07F2-44B7-B923-A7C94697DB5EQ27473455-3297A624-9D35-47CA-8405-3CAA295F2A19Q27477468-4B140F67-1C45-4E93-9AC5-760E163F7188Q27477625-363EEE9C-C687-4544-AA09-D67DA2DB785FQ27477687-16ED83DD-5F34-4CE3-97BA-2ACA58A36268Q27477777-ED85A98E-B4FC-42F2-BE3F-16E3E3061586Q27478129-7EE9461F-FB6A-4B36-97E5-103A00D72698Q27480367-6F39B76F-03B5-450E-9472-0A5CBDA8C802Q27481012-80DECCFC-C698-4AEC-9369-FCD53C8CB01CQ27485530-218FD05D-7D61-4905-89A1-3012B90CC904Q27485638-3D3B2E38-A3CE-4511-9663-EB45999B3EA8Q27485659-4EF5FF99-404F-4535-B0F4-6DD00B0B2725Q27486789-5CAE7F4D-4741-41AC-90E5-9617A4096583Q27486897-446A55FA-DC6A-4B87-B63B-017BFE32A8D0Q27487399-BE35D87B-9F38-4387-8F4D-1F6918CA146CQ27487872-93829B2B-6E11-4E68-BDB2-524135DF1D16Q27489898-29CD7048-FA06-4006-A981-E787C8EB091F
P2860
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR
@ast
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR
@en
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR
@nl
type
label
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR
@ast
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR
@en
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR
@nl
altLabel
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
@en
prefLabel
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR
@ast
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR
@en
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR
@nl
P2093
P2860
P50
P3181
P1433
P1476
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR
@en
P2093
Angela Granelli-Piperno
Charles M Rice
George J Leslie
George Lin
Robert W Doms
Zhiwei Chen
P2860
P304
P3181
P356
10.1128/JVI.77.7.4070-4080.2003
P407
P577
2003-04-01T00:00:00Z